Patents by Inventor Raphael LEHRER

Raphael LEHRER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Individualized cancer treatment
    Patent number: 10262103
    Abstract: Methods to formulate treatments for individual cancer patients by assessing genomic and/or phenotypic differences between cancer and normal tissues and integrating the results to identify dysfunctional pathways are described.
    Type: Grant
    Filed: November 18, 2009
    Date of Patent: April 16, 2019
    Inventors: Raphael Lehrer, Robert Coopersmith
  • METHOD TO IMPROVE EXPRESSION AND OTHER BIOLOGICAL ANALYSIS
    Publication number: 20160040248
    Abstract: A method to verify single data points by substituting multiple data points that predict the original value measured is described. This is applied to determining gene expression levels.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 11, 2016
    Applicant: Genekey Corporation
    Inventor: Raphael LEHRER
  • Method to treat melanoma in BRAF inhibitor-resistant subjects
    Patent number: 8426418
    Abstract: Methods to treat cancer patients, especially melanoma patients, who have BRAF mutations and have become resistant to BRAF mutant kinase inhibitors employ inhibitors of multiple receptor tyrosine kinases. In addition, methods are described for identifying pharmaceutical compositions and drugs that will be successful in treating these patients.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: April 23, 2013
    Assignee: CollabRx Inc.
    Inventors: Robert Coopersmith, Raphael Lehrer
  • METHOD TO TREAT MELANOMA IN BRAF INHIBITOR-RESISTANT SUBJECTS
    Publication number: 20120053185
    Abstract: Methods to treat cancer patients, especially melanoma patients, who have BRAF mutations and have become resistant to BRAF mutant kinase inhibitors employ inhibitors of multiple receptor tyrosine kinases. In addition, methods are described for identifying pharmaceutical compositions and drugs that will be successful in treating these patients.
    Type: Application
    Filed: August 26, 2011
    Publication date: March 1, 2012
    Applicant: CollabRx Inc.
    Inventors: Robert COOPERSMITH, Raphael Lehrer
  • INDIVIDUALIZED CANCER TREATMENT
    Publication number: 20100130527
    Abstract: Methods to formulate treatments for individual cancer patients by assessing genomic and/or phenotypic differences between cancer and normal tissues and integrating the results to identify dysfunctional pathways are described.
    Type: Application
    Filed: November 18, 2009
    Publication date: May 27, 2010
    Inventors: Raphael LEHRER, Robert Coopersmith